482 related articles for article (PubMed ID: 19514717)
1. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.
Ali MM; Liu G; Shah T; Flask CA; Pagel MD
Acc Chem Res; 2009 Jul; 42(7):915-24. PubMed ID: 19514717
[TBL] [Abstract][Full Text] [Related]
2. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
3. A review of optimization and quantification techniques for chemical exchange saturation transfer MRI toward sensitive in vivo imaging.
Kim J; Wu Y; Guo Y; Zheng H; Sun PZ
Contrast Media Mol Imaging; 2015; 10(3):163-178. PubMed ID: 25641791
[TBL] [Abstract][Full Text] [Related]
4. Measuring in vivo tumor pHe with CEST-FISP MRI.
Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
[TBL] [Abstract][Full Text] [Related]
5. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
[TBL] [Abstract][Full Text] [Related]
6. Quantitative description of radiofrequency (RF) power-based ratiometric chemical exchange saturation transfer (CEST) pH imaging.
Wu R; Longo DL; Aime S; Sun PZ
NMR Biomed; 2015 May; 28(5):555-65. PubMed ID: 25807919
[TBL] [Abstract][Full Text] [Related]
7. Calcium-responsive paramagnetic CEST agents.
Angelovski G; Chauvin T; Pohmann R; Logothetis NK; Tóth E
Bioorg Med Chem; 2011 Feb; 19(3):1097-105. PubMed ID: 20691598
[TBL] [Abstract][Full Text] [Related]
8. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications.
Aime S; Barge A; Delli Castelli D; Fedeli F; Mortillaro A; Nielsen FU; Terreno E
Magn Reson Med; 2002 Apr; 47(4):639-48. PubMed ID: 11948724
[TBL] [Abstract][Full Text] [Related]
9. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.
Ali MM; Yoo B; Pagel MD
Mol Pharm; 2009; 6(5):1409-16. PubMed ID: 19298054
[TBL] [Abstract][Full Text] [Related]
10. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging.
Woods M; Woessner DE; Sherry AD
Chem Soc Rev; 2006 Jun; 35(6):500-11. PubMed ID: 16729144
[TBL] [Abstract][Full Text] [Related]
11. Lanthanide-loaded erythrocytes as highly sensitive chemical exchange saturation transfer MRI contrast agents.
Ferrauto G; Delli Castelli D; Di Gregorio E; Langereis S; Burdinski D; Grüll H; Terreno E; Aime S
J Am Chem Soc; 2014 Jan; 136(2):638-41. PubMed ID: 24359116
[TBL] [Abstract][Full Text] [Related]
12. CEST and PARACEST MR contrast agents.
Hancu I; Dixon WT; Woods M; Vinogradov E; Sherry AD; Lenkinski RE
Acta Radiol; 2010 Oct; 51(8):910-23. PubMed ID: 20828299
[TBL] [Abstract][Full Text] [Related]
13. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI.
Woessner DE; Zhang S; Merritt ME; Sherry AD
Magn Reson Med; 2005 Apr; 53(4):790-9. PubMed ID: 15799055
[TBL] [Abstract][Full Text] [Related]
14. Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.
Liu G; Liang Y; Bar-Shir A; Chan KW; Galpoththawela CS; Bernard SM; Tse T; Yadav NN; Walczak P; McMahon MT; Bulte JW; van Zijl PC; Gilad AA
J Am Chem Soc; 2011 Oct; 133(41):16326-9. PubMed ID: 21919523
[TBL] [Abstract][Full Text] [Related]
15. Free-base porphyrins as CEST MRI contrast agents with highly upfield shifted labile protons.
Zhang X; Yuan Y; Li S; Zeng Q; Guo Q; Liu N; Yang M; Yang Y; Liu M; McMahon MT; Zhou X
Magn Reson Med; 2019 Aug; 82(2):577-585. PubMed ID: 30968442
[TBL] [Abstract][Full Text] [Related]
16. Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.
Bagga P; Haris M; D'Aquilla K; Wilson NE; Marincola FM; Schnall MD; Hariharan H; Reddy R
J Transl Med; 2017 May; 15(1):119. PubMed ID: 28558795
[TBL] [Abstract][Full Text] [Related]
17. Lanthanide ion (III) complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraaminophosphonate for dual biosensing of pH with chemical exchange saturation transfer (CEST) and biosensor imaging of redundant deviation in shifts (BIRDS).
Huang Y; Coman D; Ali MM; Hyder F
Contrast Media Mol Imaging; 2015; 10(1):51-8. PubMed ID: 24801742
[TBL] [Abstract][Full Text] [Related]
18. Entrapment of a neutral Tm(III)-based complex with two inner-sphere coordinated water molecules into PEG-stabilized vesicles: towards an alternative strategy to develop high-performance LipoCEST contrast agents for MR imaging.
Chahid B; Vander Elst L; Flament J; Boumezbeur F; Medina C; Port M; Muller RN; Lesieur S
Contrast Media Mol Imaging; 2014; 9(6):391-9. PubMed ID: 24760773
[TBL] [Abstract][Full Text] [Related]
19. Responsive MRI agents for sensing metabolism in vivo.
De Leon-Rodriguez LM; Lubag AJ; Malloy CR; Martinez GV; Gillies RJ; Sherry AD
Acc Chem Res; 2009 Jul; 42(7):948-57. PubMed ID: 19265438
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
